InterMune, Inc.

InterMune, Inc.

InterMune, Inc.

Overview
Date Founded

2000

Headquarters

1 DNA Way,South San Francisco, CA 94080

Type of Company

Private

Employees (Worldwide)

251 - 500

Industries

Biotechnology
Pharmaceuticals

Company Description

InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA.

Contact Data
Trying to get in touch with decision makers at InterMune, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Non-Executive Chairman & Chief Executive Officer

Chief Financial Officer & Senior Vice President-Administration

Executive Vice President & Managing Director-Europe Region

Senior Vice President, Human Resources

Senior Vice President, Research & Technical Development

Senior Vice President, Human Resources & Administration

General Manager France

Investor

Senior Director

Senior Director

Board of Directors

Executive Chairman at Incarda Therapeutics, Inc.

Member, Board of Directors at InterMune, Inc.

Vice Chairman at ScienceIndustries

In-House Counsel at Roche Holding AG

Professional at Castlepoint Holdings Ltd.

Paths to InterMune, Inc.
Potential Connections via
Relationship Science
You
InterMune, Inc.
Recent Transactions
Details Hidden

Roche Holding AG purchases InterMune, Inc.

Details Hidden

InterMune, Inc. issued USD Common Stock

Details Hidden

InterMune, Inc. issued USD Common Stock

Transaction Advisors
Investment Advisor

Advised onRoche Holding AG purchases InterMune, Inc.

Underwriter

Advised onInterMune, Inc. issued USD Common Stock

Underwriter

Advised onInterMune, Inc. issued USD Common Stock

Legal Advisor

Advised onInterMune, Inc. issued USD Common Stock

Underwriter

Advised onInterMune, Inc. issued USD Common Stock

Underwriter

Advised onInterMune, Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner at Latham & Watkins LLP

Legal Advisor

Partner at Gibson, Dunn & Crutcher LLP

Legal Advisor

Partner, San Francisco at Cooley LLP

Key Stats and Financials As of
Market Capitalization
$7.93B
Total Enterprise Value
Earnings Per Share
Non-Profit Donations & Grants
Investors
Details Hidden

Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA.

Details Hidden

General Partner at Sofinnova Investments, Inc.

Details Hidden

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by InterMune, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of InterMune, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and InterMune, Inc..